Our study found that both L929-MVs and MSC-MVs were effective in increasing the relative abundance of Tregs and decreasing the levels of pro-inflammatory CD4+CD44+ T cells in the spleens of AKI mice. This evidence concerns the gene CD44 and acute kidney injury.